66 related articles for article (PubMed ID: 11276542)
1. Sex-specific determinants of HIV infection among injection drug users in Montreal.
Bruneau J; Lamothe F; Soto J; Lachance N; Vincelette J; Vassal A; Franco EL
CMAJ; 2001 Mar; 164(6):767-73. PubMed ID: 11276542
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.
Barrio G; De La Fuente L; Toro C; Brugal TM; Soriano V; Gonzalez F; Bravo MJ; Vallejo F; Silva TC;
Epidemiol Infect; 2007 May; 135(4):592-603. PubMed ID: 17005071
[TBL] [Abstract][Full Text] [Related]
3. The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users.
Washington TA; Galai N; Cohn S; Celentano DD; Vlahov D; Strathdee SA
Arch Sex Behav; 2006 Feb; 35(1):67-74. PubMed ID: 16502154
[TBL] [Abstract][Full Text] [Related]
4. Drug injection among street youths in Montreal: predictors of initiation.
Roy E; Haley N; Leclerc P; Cédras L; Blais L; Boivin JF
J Urban Health; 2003 Mar; 80(1):92-105. PubMed ID: 12612099
[TBL] [Abstract][Full Text] [Related]
5. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
[TBL] [Abstract][Full Text] [Related]
6. Portraying persons who inject drugs recently infected with hepatitis C accessing antiviral treatment: a cluster analysis.
Bamvita JM; Roy E; Zang G; Jutras-Aswad D; Artenie AA; Levesque A; Bruneau J
Hepat Res Treat; 2014; 2014():631481. PubMed ID: 25349730
[TBL] [Abstract][Full Text] [Related]
7. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
[TBL] [Abstract][Full Text] [Related]
8. Differential risk factors for HIV drug and sex risk-taking among non-treatment-seeking hospitalized injection drug users.
Crooks D; Tsui J; Anderson B; Dossabhoy S; Herman D; Liebschutz JM; Stein MD
AIDS Behav; 2015 Mar; 19(3):405-11. PubMed ID: 25063229
[TBL] [Abstract][Full Text] [Related]
9. Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: a cross-sectional study.
Ghimire B; Suguimoto SP; Zamani S; Ono-Kihara M; Kihara M
BMC Public Health; 2013 Dec; 13():1238. PubMed ID: 24373529
[TBL] [Abstract][Full Text] [Related]
10. Modulation of intracellular restriction factors contributes to methamphetamine-mediated enhancement of acquired immune deficiency syndrome virus infection of macrophages.
Wang X; Wang Y; Ye L; Li J; Zhou Y; Sakarcan S; Ho W
Curr HIV Res; 2012 Jul; 10(5):407-14. PubMed ID: 22591364
[TBL] [Abstract][Full Text] [Related]
11. The influence of the perceived consequences of refusing to share injection equipment among injection drug users: balancing competing risks.
Wagner KD; Lankenau SE; Palinkas LA; Richardson JL; Chou CP; Unger JB
Addict Behav; 2011 Aug; 36(8):835-42. PubMed ID: 21498004
[TBL] [Abstract][Full Text] [Related]
12. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.
Bruneau J; Daniel M; Abrahamowicz M; Zang G; Lamothe F; Vincelette J
Am J Epidemiol; 2011 May; 173(9):1049-58. PubMed ID: 21362739
[TBL] [Abstract][Full Text] [Related]
13. Difficulty accessing syringes mediates the relationship between methamphetamine use and syringe sharing among young injection drug users.
Marshall BD; Shoveller JA; Wood E; Patterson TL; Kerr T
AIDS Behav; 2011 Oct; 15(7):1546-53. PubMed ID: 21197598
[TBL] [Abstract][Full Text] [Related]
14. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.
Wang X; Ho WZ
Life Sci; 2011 May; 88(21-22):972-9. PubMed ID: 21056582
[TBL] [Abstract][Full Text] [Related]
15. Drugs of abuse, immune modulation, and AIDS.
Cabral GA
J Neuroimmune Pharmacol; 2006 Sep; 1(3):280-95. PubMed ID: 18040805
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of endemicity in urban environments: a hypothesis linking risk, network structure and geography.
Rothenberg R
Sex Transm Infect; 2007 Feb; 83(1):10-5. PubMed ID: 17283360
[TBL] [Abstract][Full Text] [Related]
17. Trends in production, trafficking, and consumption of methamphetamine and cocaine in Mexico.
Brouwer KC; Case P; Ramos R; Magis-Rodríguez C; Bucardo J; Patterson TL; Strathdee SA
Subst Use Misuse; 2006; 41(5):707-27. PubMed ID: 16603456
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence.
Elkader A; Sproule B
Clin Pharmacokinet; 2005; 44(7):661-80. PubMed ID: 15966752
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland.
Plitt SS; Sherman SG; Strathdee SA; Taha TE
Sex Transm Infect; 2005 Jun; 81(3):248-53. PubMed ID: 15923296
[TBL] [Abstract][Full Text] [Related]
20. Women and HIV.
Gatali M; Archibald C
BMC Womens Health; 2004 Aug; 4 Suppl 1(Suppl 1):S27. PubMed ID: 15345090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
